Advocacy.
CCI and its member organisations engage in global, regional and national advocacy to drive policy change and health sector reforms on childhood cancer.
Among the outcomes of noteworthy successful CCI advocacy are:
Financial and budgetary allocation for childhood cancer research, facilities and key programs;
Sustainable availability and access to safe, affordable, effective essential childhood cancer medicines;
Making childhood cancer drugs more affordable due to government initiated price controls;
More robust health regulations and standards;
Scaled up research and clinical trials;
Improved social health insurance coverage;
Active family and patient engagement in health systems and facilities;
Programs for health care surveillance and quality long term follow-up care of survivors.
CCI and its member organisations also undertake media advocacy in all levels, to encourage media organisations to spotlight and prominently feature childhood cancer stories, issues, awareness and advocacy campaigns.
In addition, CCI undertakes social advocacy to build momentum for change and mobilize widespread support from multiple sectors.
Highlights.
CCI granted UN ECOSOC Special Consultive Status.
In July 2010, the United Nations Economic and Social Council (ECOSOC), adopted the recommendation of the Committee on Non-Governmental Organisations (NGOs), to grant Special consultative status to Childhood Cancer International. The consultative status opens the door for CCI to actively engage with the ECOSOC and its subsidiary bodies, as well as with United Nations Secretariat, programmes, funds and agencies.
CCI included in the WHO Register of Non-State Actors.
In January 2018, the WHO Executive Board admitted Childhood Cancer International into official Relations with the World Health Organisation.